Jung‐Shin Lee

7.5k total citations · 1 hit paper
110 papers, 4.8k citations indexed

About

Jung‐Shin Lee is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jung‐Shin Lee has authored 110 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 37 papers in Oncology and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jung‐Shin Lee's work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (15 papers) and Epigenetics and DNA Methylation (14 papers). Jung‐Shin Lee is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (15 papers) and Epigenetics and DNA Methylation (14 papers). Jung‐Shin Lee collaborates with scholars based in South Korea, United States and Taiwan. Jung‐Shin Lee's co-authors include Ali Shilatifard, Edwin R. Smith, Sang‐We Kim, Dae Ho Lee, Cheolwon Suh, Michael P. Washburn, Laurence Florens, Jessica Schneider, Selene K. Swanson and Je‐Hwan Lee and has published in prestigious journals such as Cell, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Jung‐Shin Lee

104 papers receiving 4.7k citations

Hit Papers

First-SIGNAL: First-Line ... 2012 2026 2016 2021 2012 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jung‐Shin Lee South Korea 31 2.4k 1.4k 1.3k 514 376 110 4.8k
Paola Rizzo Italy 41 2.7k 1.1× 2.0k 1.4× 1.4k 1.1× 175 0.3× 720 1.9× 121 6.1k
Keiko Hiyama Japan 35 3.0k 1.2× 853 0.6× 787 0.6× 161 0.3× 669 1.8× 128 6.4k
Kah Keng Wong Malaysia 27 1.6k 0.7× 1.3k 0.9× 1.1k 0.8× 168 0.3× 307 0.8× 111 3.7k
Andra R. Frost United States 44 3.3k 1.4× 1.8k 1.2× 622 0.5× 177 0.3× 1.1k 3.0× 120 5.7k
Fritz Wrba Austria 38 1.2k 0.5× 1.6k 1.1× 985 0.8× 298 0.6× 545 1.4× 167 4.7k
Lee Goodglick United States 42 2.6k 1.1× 1.5k 1.0× 1.5k 1.2× 130 0.3× 804 2.1× 98 5.5k
Lei Shen China 39 1.6k 0.7× 1.5k 1.0× 2.4k 1.9× 308 0.6× 1.1k 3.0× 142 4.6k
James C. Cusack United States 35 2.6k 1.1× 2.7k 1.8× 507 0.4× 314 0.6× 1.3k 3.4× 89 5.1k
Federica Gemignani Italy 37 2.3k 0.9× 969 0.7× 523 0.4× 126 0.2× 1.2k 3.2× 111 4.1k
Masayoshi Namba Japan 35 2.8k 1.1× 1.1k 0.8× 293 0.2× 228 0.4× 533 1.4× 186 4.8k

Countries citing papers authored by Jung‐Shin Lee

Since Specialization
Citations

This map shows the geographic impact of Jung‐Shin Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung‐Shin Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung‐Shin Lee more than expected).

Fields of papers citing papers by Jung‐Shin Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung‐Shin Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung‐Shin Lee. The network helps show where Jung‐Shin Lee may publish in the future.

Co-authorship network of co-authors of Jung‐Shin Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Jung‐Shin Lee. A scholar is included among the top collaborators of Jung‐Shin Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung‐Shin Lee. Jung‐Shin Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Shinae, Jae‐Hoon Lee, Jae‐Hoon Lee, et al.. (2025). Phosphatase regulation in cell division: With emphasis on PP2A-B56. Molecules and Cells. 48(9). 100255–100255.
2.
Jang, Young‐Saeng, Jung Tak Park, Seung Goo Kang, et al.. (2023). Combined Treatment With TGF-β1, Retinoic Acid, and Lactoferrin Robustly Generate Inducible Tregs (iTregs) Against High Affinity Ligand. Immune Network. 23(5). e37–e37. 2 indexed citations
3.
Kim, Kyeongkyu, et al.. (2022). ROS inhibits RORα degradation by decreasing its arginine methylation in liver cancer. Cancer Science. 114(1). 187–200. 10 indexed citations
4.
Kim, Ju-Eun & Jung‐Shin Lee. (2019). Rapid method for chromatin immunoprecipitation (ChIP) assay in a dimorphic fungus, Candida albicans. The Journal of Microbiology. 58(1). 11–16. 6 indexed citations
5.
Yoo, Changhoon, Shinkyo Yoon, Dae Ho Lee, et al.. (2015). Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non–Small-Cell Lung Cancer After Curative Resection. Clinical Lung Cancer. 16(6). e203–e212. 30 indexed citations
6.
Park, Sojung, Tai Sun Park, Chang‐Min Choi, et al.. (2015). Survival Benefit of Pemetrexed in Lung Adenocarcinoma Patients With Anaplastic Lymphoma Kinase Gene Rearrangements. Clinical Lung Cancer. 16(5). e83–e89. 39 indexed citations
7.
Oh, Jang‐Hyun, et al.. (2015). Ssn6 has dual roles in Candida albicans filament development through the interaction with Rpd31. FEBS Letters. 589(4). 513–520. 22 indexed citations
8.
Kim, Yeon Joo, Si Yeol Song, Seong‐Yun Jeong, et al.. (2015). Definitive radiotherapy with or without chemotherapy for clinical stage T4N0-1 non-small cell lung cancer. Radiation Oncology Journal. 33(4). 284–284. 7 indexed citations
9.
Kim, Jueun, Jieun Lee, & Jung‐Shin Lee. (2015). Histone deacetylase-mediated morphological transition in Candida albicans. The Journal of Microbiology. 53(12). 805–811. 26 indexed citations
10.
Kim, Ho Cheol, Joon Seon Song, Jae Cheol Lee, et al.. (2014). Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.. PubMed. 7(10). 6743–51. 9 indexed citations
11.
Shi, Ming‐Der, et al.. (2013). CXCL12-G801A polymorphism modulates risk of colorectal cancer in Taiwan. Archives of Medical Science. 6(6). 999–1005. 18 indexed citations
12.
Lee, Yi‐Chieh, Jung‐Shin Lee, Yichen Liao, et al.. (2010). Nobiletin, a citrus flavonoid, suppresses invasion and migration involving FAK/PI3K/Akt and small GTPase signals in human gastric adenocarcinoma AGS cells. Molecular and Cellular Biochemistry. 347(1-2). 103–115. 100 indexed citations
14.
Sohn, Hee-Jung, Jin‐Sook Ryu, Seung Jun Oh, et al.. (2008). [18F]Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the Lung. Clinical Cancer Research. 14(22). 7423–7429. 125 indexed citations
15.
Lee, Je‐Hwan, Seong‐Jun Choi, Jung‐Hee Lee, et al.. (2005). Continuous infusion intermediate-dose cytarabine, mitoxantrone, plus etoposide for refractory or early relapsed acute myelogenous leukemia. Leukemia Research. 30(2). 204–210. 10 indexed citations
16.
Lee, Jae‐Lyun, Jae‐Lyun Lee, Sung‐Bae Kim, et al.. (2003). Collection of peripheral blood progenitor cells: analysis of factors predicting the yields. Transfusion and Apheresis Science. 29(1). 29–37. 24 indexed citations
17.
Sohn, Hee-Jung, Eun-Kyung Kim, Gyeong‐Won Lee, et al.. (2003). Survival according to Treatment Modalities in 137 Patients with Aplastic Anemia. Blood Research. 38(1). 1–7.
18.
Ryu, Min‐Hee, et al.. (2002). A Case of Chylous Ascites Associated with Non-Hodgkin's Lymphoma and Liver Cirrhosis. Blood Research. 37(3). 236–240. 1 indexed citations
19.
Lee, Je‐Hwan, Je‐Hwan Lee, Jin Hee Ahn, et al.. (2001). Combination chemotherapy utilizing continuous infusion of intermediate-dose cytarabine for refractory or recurrent acute myeloid leukemia. Leukemia Research. 25(3). 213–216. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026